Valuation: MedCap AB

Market Cap 769Cr 77Cr 68Cr 64Cr 58Cr 109.23Cr 7.37TCr 110.25Cr 297.99Cr 3.77TCr 287.7Cr 281.45Cr 12TCr P/E 2026 *
30.3x
P/E 2027 * 25.7x
Enterprise Value 777.3Cr 77Cr 69Cr 64Cr 59Cr 110.41Cr 7.45TCr 111.44Cr 301.2Cr 3.81TCr 290.8Cr 284.49Cr 12TCr EV / Sales 2026 *
3.24x
EV / Sales 2027 * 2.81x
Free-Float
88.3%
Yield 2026 *
-
Yield 2027 * -
1 day-0.24%
1 week-3.03%
Current month-2.39%
1 month-7.84%
3 months-6.32%
6 months+7.68%
Current year-6.83%
1 week 507
Extreme 507
537
1 month 507
Extreme 507
575.5
Current year 440
Extreme 440
582
1 year 440
Extreme 440
636
3 years 247
Extreme 247
677
5 years 135
Extreme 135
677
10 years 27
Extreme 27
677
Manager TitleAgeSince
Chief Executive Officer 50 01/11/2020
Director of Finance/CFO 52 30/04/2020
Corporate Officer/Principal 54 01/01/2020
Director TitleAgeSince
Chairman 52 01/01/2008
Director/Board Member 63 01/05/2022
Director/Board Member 66 01/05/2022
Date Insider Type Main position Quantity % Market Cap. Importance
09/02/26 Buy 1,500 0.0099%
09/02/26
Anders Larnholt Forvaltning AB
SellCompany 1,500 0.0099%
06/02/26 Sell 500 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-3.03%-9.79%+87.71% 77Cr
+0.61%-1.43%-7.73%+66.52% 16TCr
+1.20%-3.11%+23.45%+76.32% 14TCr
+1.11%-2.96%+36.97%+246.34% 9.77TCr
+0.61%-4.58%-32.17%+5.45% 8.98TCr
-0.37%-5.99%-27.08%+49.01% 8.19TCr
+1.75%+1.44%-16.62%+92.55% 8.14TCr
+0.73%+1.17%-19.52%+45.41% 7.11TCr
+1.01%-2.63%+53.37%+166.75% 4.8TCr
-0.63%-0.15%+0.32%+51.06% 4.37TCr
Average +0.57%-1.95%+0.12%+88.71% 8.23TCr
Weighted average by Cap. +0.75%-1.86%+0.52%+86.95%

Financials

2026 *2027 *
Net sales 239.8Cr 24Cr 21Cr 20Cr 18Cr 34Cr 2.3TCr 34Cr 93Cr 1.17TCr 90Cr 88Cr 3.77TCr 268.6Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.57TCr 39Cr 104.08Cr 1.32TCr 100.49Cr 98Cr 4.22TCr
Net income 26Cr 2.57Cr 2.28Cr 2.13Cr 1.94Cr 3.66Cr 247.14Cr 3.7Cr 10Cr 126.34Cr 9.65Cr 9.44Cr 405.48Cr 32Cr 3.18Cr 2.82Cr 2.64Cr 2.4Cr 4.53Cr 305.58Cr 4.57Cr 12Cr 156.21Cr 12Cr 12Cr 501.35Cr
Net Debt 8.3Cr 82.71L 73.48L 68.59L 62.51L 1.18Cr 80Cr 1.19Cr 3.22Cr 41Cr 3.11Cr 3.04Cr 130.44Cr -16Cr -1.54Cr -1.37Cr -1.28Cr -1.17Cr -2.2Cr -148.48Cr -2.22Cr -6.01Cr -76Cr -5.8Cr -5.67Cr -243.6Cr
Logo MedCap AB
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Employees
647
Date Price Change Volume
02/26/02 SEK 511.50 -0.39% 44,850
01/26/01 SEK 513.50 -2.00% 28,854
30/26/30 SEK 524.00 +1.26% 24,795
29/26/29 SEK 517.50 -2.17% 12,393
28/26/28 SEK 529.00 +0.28% 15,742
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
513.50SEK
Average target price
640.00SEK
Spread / Average Target
+24.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MCAP Stock